Prognostic significance of pretherapeutic and therapeutic factors in patients with advanced cancer of the uterine cervix treated with radical radiotherapy alone

Acta Oncologica

Volumn 38, Issue 4, 1999, Pages 461-468

  Karolewski, Kazimierz ^a   Korzeniowski, Stanisław ^a   Sokołowski, Andrzej ^b   Urbański, Krzysztof ^a   Kojs, Zbigniew ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b CRACOW UNIVERSITY OF ECONOMICS   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ABORTION; ADULT; AGE; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; UTERINE CERVIX CANCER;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LINEAR MODELS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0033018747     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431997     Document Type: Article

References (44)

1. 1. Zatoński WA. Nowotwory złośliwe w Polsce. Warszawa: Centrum Onkologii, 1993.
2. 2. Koszarowski J, Gadomska H, Wronkowski Z, Romejko M. Epidemiologia nowotworów złośliwych w Polsce w latach 1952-1982. Nowotwory 1985; 35: 93-113.
3. 3. Tarlowska L, Kamińska G, Mielcarzewicz Z, et al. Zmiany zachodzace w składzie i wynikach leczenia chorych na raka szyjki macicy badanych i leczonych w polskich zakładach onkologicznych. Nowotwory 1979; 29: 183-99.
4. 4. Horiot JC, Pigneux J, Pourquier H, et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher/Guìdelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 1988; 14: 605-11.
5. 5. Hunter RD, Cowie VJ, Blair V, Cole MP. A clinical trial of two conceptually different radical radiotherapy treatments in stage III carcinoma of the cervix. Clin Radiol 1986; 37: 23-7.
6. 6. Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 1991; 20: 667-76.
7. 7. Montana GS, Fowler WC, Varia MA, Walton LA, Marck Y, Shemanski L. Carcinoma of the cervix stage III. Results of radiation therapy. Cancer 1986; 57: 148-54.
8. 8. Perez CA, Breaux S, Madoc-Jones H, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. I. Analysis of tumor recurrence. Cancer 1983; 51: 1393-402.
9. 9. Perez CA, DiSaia PJ, Knapp RC. Gynecologic tumors. In: Cancer principles and practice of oncology. 2nd ed. Philadelphia: J.B. Lipincott, 1985: 1013-41.
10. 10. Yoonessi M. Treatment of advanced invasive cervical cancer. Changing times and trends. J Surg Oncol 1984; 26: 161-7.
11. 11. Szymczyk W, Siuda J, Medvey W, Polak B, Polok B, Rozkład dawek w obrȩbie miednicy mnieszej w leczeniu raka szyjki macicy. Pol Przegl Rad I Med Nukl 1971; XXXV: 475-80.
12. 12. Ellis F. Sorensen A. A method of estimating biological effect of combined intracavitary low dose rate radiation with external radiation in carcinoma of the cervix uteri. Radiology 1974; 110: 681-6.
13. 13. Orton CG. Time dose factors (TDFs) in brachytherapy. Br J Radiol 1974; 47: 603-7.
14. 14. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-220.
15. 15. Fagundes H, Perez CA, Grigsby PW, Lockett MA. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1992; 24: 197-204.
16. 16. Fletcher GH. Squamous cell carcinoma of the uterine cervix. In: Textbook of radiotherapy. Philadelphia: Lea and Febiger, 1980: 720-73.
17. 17. Pettersson F. Annual report on the results of treatment of gynecological cancer. International Federation of Gynecology and Obstetrics, vol. 21. Stockholm, 1993.
18. 18. Ashby MA, Smales E. Invasive carcinoma of the cervix in young women: clinical data and prognostic features. Radiother Oncol 1987; 10: 167-74.
19. 19. Benstead K, Cowie VJ, Blair V, Hunter RD. Stage III carcinoma of the cervix. The importance of increasing age and extent of parametrial infiltration. Radiother Oncol 1986; 5: 271-6.
20. 20. Carmichael JA, Clarke DH, Moher D, Ohlke ID, Karchmar EJ. Cervical carcinoma in women aged 34 and younger. Am J Obstet Gynecol 1986; 2: 264-8.
21. 21. Kapp DS, Fischer D, Gutierrez E, Kohorn FJ, Schwartz PE. Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology and blood counts on survival. Int J Radiol Oncol Biol Phys 1983; 9: 445-55.
22. 22. Spanos WJ, King A, Keeney E, Wagner R, Slater JM. Age as a prognostic factor in carcinoma of the cervix. Gynecol Oncol 1989; 35: 66-8.
23. 23. Jampolis S, Andras EJ, Fletcher GH. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology 1978; 115: 681-5.
24. 24. Perez CA, Camel HM, Askin F, Breaux S. Endometrial extension of carcinoma of the uterine cervix: a prognostic factor that may modify staging. Cancer 1981; 48: 170-80.
25. 25. Bush RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 1986; 12: 2047-50.
26. 26. Dische S, Anderson PJ. Carcinoma of the cervix - anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol 1983; 56: 251-255.
27. 27. Girinsky T, Pejovic MH, Bourhis J, et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989; 16: 37-42.
28. 28. Höckel M, Vorndran B, Schlenger K, Baussman E, Knapstein PG. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 1993; 51: 141-149.
29. 29. Pedersen D, Sogaard H, Overgaard J, Bentzen SM. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. Acta Oncol 1995; 34: 787-95.
30. 30. Schneider A. HPV infections in women and their male partners. Contemp Obstet Gynecol 1988; 32: 131.
31. 31. Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-on-care study. Int J Radiat Oncol Biol Phys 1993; 25: 391-397.
32. 32. Barton MB, Keane TJ, Gadalla T, Maki E. The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992; 23: 137-43.
33. 33. Bentzen S, Johansen LV, Overgaard J, Thames HD. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1991; 20: 1197-1206.
34. 34. Fowler JF, Tanner MA, Bataini JP, Asselain B, Bernier J, Lave C. Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother Oncol 1990; 19: 237-44.
35. 35. Keane TJ, Fyles A, O'Sullivan B, Barton M, Maki E, Simm J. The effect of treatment duration on local control of squamous carcinoma of the tonsil and carcinoma of the cervix. Semin Rad Oncol 1992; 2: 26-8.
36. 36. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-46.
37. 37. Eifel PJ, Thames HD. Has the influence of treatment duration on local control of carcinoma of the cervix been defined? Int J Radiat Oncol Biol Phys 1995; 32: 1527-9.
38. 38. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in local control of cervix cancer. Radiother Oncol 1992; 25: 273-9.
39. 39. Girinsky T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993; 27: 1051-6.
40. 40. Mendenhall WM, Thar TL, Bova FJ, Marcus RB, Morgan LS, Million RR. Prognostic and treatment factors affecting pelvic control of stage IB and IIA B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 1984; 53: 2649-54.
41. 41. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA, Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995; 32: 1275-88.
42. 42. Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1301-7.
43. 43. Keys H, Gibbons SK. Optimal management of locally advanced cervical carcinoma. J Natl Cancer Inst Monogr 1996; 21: 89-92.
44. 44. Perez CA, Grigsby PW, Nene SM, et al. Effect of tumor size on prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992; 69: 2796-806.